List of Contents

Blood Bank Market Size, Share, and Trends 2024 to 2034

The global blood bank market size is estimated at USD 18.58 billion in 2024, grew to USD 19.26 billion in 2025 and is predicted to surpass around USD 26.61 billion by 2034, expanding at a CAGR of 3.66% between 2024 and 2034. The North America blood bank market size accounted for USD 8.36 billion in 2024 and is anticipated to grow at a fastest CAGR of 3.77% during the forecast year.

  • Last Updated : November 2024
  • Report Code : 2537
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Bank Market 

5.1. COVID-19 Landscape: Blood Bank Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Bank Market, By Product

8.1. Blood Bank Market, by Product, 2024-2034

8.1.1. Whole Blood

8.1.1.1. Market Revenue and Forecast (2021-2034)

8.1.2. Red Blood Cells

8.1.2.1. Market Revenue and Forecast (2021-2034)

8.1.3. Platelets

8.1.3.1. Market Revenue and Forecast (2021-2034)

8.1.4. Plasma

8.1.4.1. Market Revenue and Forecast (2021-2034)

8.1.5. White Blood Cells

8.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 9. Global Blood Bank Market, By Function

9.1. Blood Bank Market, by Function, 2024-2034

9.1.1. Collection

9.1.1.1. Market Revenue and Forecast (2021-2034)

9.1.2. Processing

9.1.2.1. Market Revenue and Forecast (2021-2034)

9.1.3. Testing

9.1.3.1. Market Revenue and Forecast (2021-2034)

9.1.4. Storage

9.1.4.1. Market Revenue and Forecast (2021-2034)

9.1.5. Transportation

9.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 10. Global Blood Bank Market, By Bank Type 

10.1. Blood Bank Market, by Bank Type, 2024-2034

10.1.1. Private

10.1.1.1. Market Revenue and Forecast (2021-2034)

10.1.2. Public

10.1.2.1. Market Revenue and Forecast (2021-2034)

Chapter 11. Global Blood Bank Market, By End User 

11.1. Blood Bank Market, by End User, 2024-2034

11.1.1. Hospital

11.1.1.1. Market Revenue and Forecast (2021-2034)

11.1.2. Ambulatory Surgery Centers

11.1.2.1. Market Revenue and Forecast (2021-2034)

11.1.3. Pharmaceutical Companies

11.1.3.1. Market Revenue and Forecast (2021-2034)

11.1.4. Clinics and Nursing Homes

11.1.4.1. Market Revenue and Forecast (2021-2034)

11.1.5. Others

11.1.5.1. Market Revenue and Forecast (2021-2034)

Chapter 12. Global Blood Bank Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.2. Market Revenue and Forecast, by Function (2021-2034)

12.1.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.1.4. Market Revenue and Forecast, by End User (2021-2034)

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.1.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.1.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.1.6.2. Market Revenue and Forecast, by Function (2021-2034)

12.1.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.1.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.2. Europe

12.2.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.2. Market Revenue and Forecast, by Function (2021-2034)

12.2.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.2.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.2.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.2.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.6.2. Market Revenue and Forecast, by Function (2021-2034)

12.2.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.2.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.7.2. Market Revenue and Forecast, by Function (2021-2034)

12.2.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.2.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.2.8.2. Market Revenue and Forecast, by Function (2021-2034)

12.2.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.2.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.3. APAC

12.3.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.2. Market Revenue and Forecast, by Function (2021-2034)

12.3.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.3.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.3.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.3.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.6.2. Market Revenue and Forecast, by Function (2021-2034)

12.3.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.3.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.7.2. Market Revenue and Forecast, by Function (2021-2034)

12.3.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.3.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.3.8.2. Market Revenue and Forecast, by Function (2021-2034)

12.3.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.3.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.4. MEA

12.4.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.2. Market Revenue and Forecast, by Function (2021-2034)

12.4.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.4.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.4.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.4.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.6.2. Market Revenue and Forecast, by Function (2021-2034)

12.4.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.4.6.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.7.2. Market Revenue and Forecast, by Function (2021-2034)

12.4.7.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.4.7.4. Market Revenue and Forecast, by End User (2021-2034)

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Product (2021-2034)

12.4.8.2. Market Revenue and Forecast, by Function (2021-2034)

12.4.8.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.4.8.4. Market Revenue and Forecast, by End User (2021-2034)

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.5.2. Market Revenue and Forecast, by Function (2021-2034)

12.5.5.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.5.5.4. Market Revenue and Forecast, by End User (2021-2034)

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Product (2021-2034)

12.5.6.2. Market Revenue and Forecast, by Function (2021-2034)

12.5.6.3. Market Revenue and Forecast, by Bank Type (2021-2034)

12.5.6.4. Market Revenue and Forecast, by End User (2021-2034)

Chapter 13. Company Profiles

13.1. America's Blood Centers

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Australian Red Cross Society

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Blood Bank of Alaska

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Canadian Blood Services

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Japanese Red Cross Society

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. New York Blood Center

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Sanquin Blood Supply Foundation

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. The American Red Cross

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Vitalant

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. NHS Blood and Transplant

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client